Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 70
Filter
1.
Prague Med Rep ; 124(1): 16-32, 2023.
Article in English | MEDLINE | ID: mdl-36763828

ABSTRACT

Odontogenic infections are the most common infectious and inflammatory diseases of the maxillofacial area and problem of the causative pathogen identification is an actual task, part of a permanent process of updating and modernization of treatment and diagnostic protocols and standards. In presented study a purulent exudate from 13 patients with acute purulent odontogenic intraoral lesions was studied by bacteriological method with detection of sensitivity to antibacterial agents. Bacteriological studies showed that genus Streptococcus predominated in 69.23% cases. Pathogenic microorganisms in clinically significant concentrations (105 per 1 ml and above) (Streptococcus and Staphylococcus) were resistant to Tetracycline and Doxycycline, had moderate sensitivity to macrolides in 22.22% and resistance in 77.78%. Amoxicillin/clavulanate caused effective growth retardation in 22.22% cases and moderate delay - in 77.78% without cases of resistance. Sensitivity to cephalosporins was detected in 50.00% cases, moderate sensitivity - in 38.89%, resistance - in 11.11%. Fluoroquinolones were the most effective - sensitivity in 72.22% cases, moderate sensitivity - in 22.22%, resistance - in 5.56%. The most effective fluoroquinolones were Moxifloxacin and Ciprofloxacin. The highest resistance to antifungal agents was shown by genus Candida, antifungal susceptibility was observed only in 20.00% cases. The microbiota of purulent odontogenic inflammation in the oral cavity was identified in clinically significant concentrations in only 61.54% cases with predominance of Streptococcus. The most effective antibacterial agents for odontogenic purulent process may be considered among cephalosporins and fluoroquinolones. There is a need to repeat similar studies in other regions of Ukraine and at other times of the year.


Subject(s)
Anti-Bacterial Agents , Periostitis , Humans , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Abscess/drug therapy , Periostitis/drug therapy , Moxifloxacin , Cephalosporins , Mouth
2.
Pediatr Infect Dis J ; 41(1): e10-e15, 2022 01 01.
Article in English | MEDLINE | ID: mdl-34711782

ABSTRACT

BACKGROUND: Osteomyelitis with proliferative periostitis is a relatively uncommon inflammatory condition of the jaws, mainly characterized by periosteal formation of reactive bone. It primarily affects children and adolescences, also referred to as Garre's osteomyelitis, more frequently involving the molar region of the mandible. Cases lacking an obvious source of infection may have an immunologically mediated etiopathogenesis, falling under the spectrum of primary chronic osteomyelitis or chronic recurrent multifocal osteomyelitis (CRMO). CASE REPORT: Herein, we present a case of chronic osteomyelitis in a 6.5-year-old girl, who suffered from recurrent painful episodes of swelling of the mandible for the last 2 years, previously requiring hospitalization and administration of intravenous (IV) antibiotics and NSAIDs with limited responsiveness. The biopsy showed features consistent with osteomyelitis with proliferative periostitis. The patient was initially managed with an IV combination antibiotic regimen with only partial improvement. The possibility of an autoimmune mechanism in the context of primary chronic osteomyelitis or CRMO was considered, and immunosuppressive therapy (TNF inhibitor etanercept along with corticosteroids and methotrexate) was administered, resulting in clinical resolution. CONCLUSIONS: Osteomyelitis and its childhood variants are relatively rare and their management presents several challenges. Although typically treated with administration of antibiotics, possibly along with surgical intervention, other treatment modalities may be necessary for resilient and persistent cases. In a subset of cases, especially in the absence of local infectious factors, immunologically mediated mechanisms may play an important role and appropriate immunosuppressive therapy may be effective.


Subject(s)
Immunosuppressive Agents/therapeutic use , Mandible/pathology , Osteomyelitis/complications , Osteomyelitis/drug therapy , Periostitis/drug therapy , Anti-Bacterial Agents/therapeutic use , Biopsy , Child , Diagnosis, Differential , Disease Management , Female , Humans , Osteomyelitis/diagnosis , Periostitis/diagnosis
3.
Am J Emerg Med ; 48: 378.e1-378.e2, 2021 10.
Article in English | MEDLINE | ID: mdl-33892938

ABSTRACT

We present the case of a 2-month-old adopted female seeking evaluation in the pediatric emergency department due to a one-day history of decreased right arm movement and fussiness. The physical exam was largely unremarkable with the exception of decreased spontaneous movement of the right upper extremity, obvious discomfort with passive movement and subtle edema of the forearm. Because of concern for non-accidental trauma, plain films were obtained which revealed no signs of traumatic injury. Subsequently, a broader investigation ensued with infectious etiologies in mind. Laboratory evaluation demonstrated anemia, transaminitis, and elevated inflammatory markers. These abnormalities led to the consideration of congenitally acquired infections, specifically syphilis, and serologies were confirmatory. Ultimately, the infant was diagnosed with Pseudoparalysis of Parrot - a rare musculoskeletal manifestation secondary to painful syphilitic periostitis. As Emergency Medicine physicians, it is important to be aware of the growing burden of syphilis infection and reacquaint ourselves with its numerous presentations in the young infant.


Subject(s)
Periostitis/diagnostic imaging , Syphilis, Congenital/diagnosis , Anti-Bacterial Agents/therapeutic use , Child, Adopted , Elbow/diagnostic imaging , Female , Humans , Infant , Penicillins/therapeutic use , Periostitis/drug therapy , Radius/diagnostic imaging , Syphilis, Congenital/drug therapy , Ulna/diagnostic imaging
4.
Reumatismo ; 73(1): 44-47, 2021 Apr 19.
Article in English | MEDLINE | ID: mdl-33874646

ABSTRACT

Voriconazole is a fluorinated drug from the triazole group that is widely used in the prophylaxis and treatment of fungal infections in immunosuppressed patients. Chronic use of this medication can generate, as an adverse effect, a multifocal, asymmetric, diffuse and nodular periosteal reaction, associated with severe and disabling skeletal pain and elevated alkaline phosphatase and serum fluoride. Radiography is the imaging technique of choice for periostitis diagnosis. In general, clinical manifestations and radiographic findings disappear, when the drug is discontinued. We report the clinical case of a 44 year-old woman diagnosed with acute myeloid leukemia, who developed an invasive fungal infection treated with voriconazole after a stem cell transplant. Nine months after starting antifungal treatment, she manifested symptoms and radiological signs compatible with periostitis. Due to clinical suspicion, we decided to suspend voriconazole, with consequent resolution of clinical manifestations and radiological findings.


Subject(s)
Periostitis , Adult , Antifungal Agents/adverse effects , Female , Humans , Periostitis/chemically induced , Periostitis/diagnostic imaging , Periostitis/drug therapy , Radiography , Triazoles/adverse effects , Voriconazole/adverse effects
5.
Clin Rheumatol ; 40(11): 4749-4757, 2021 Nov.
Article in English | MEDLINE | ID: mdl-33830360

ABSTRACT

Psoriatic onycho-pachydermo periostitis (POPP) is characterized by psoriatic onychodystrophy, connective tissue thickening, and periostitis of the distal phalanges (DPs), producing a drumstick-like deformity. Our aim was to present the first case of POPP treated successfully with an IL-17 inhibitor, perform a literature review of its characteristics and treatment, and explore the possible pathogenesis. We conducted a systematic review of previously presented POPP cases. We present a patient with methotrexate (MTX)-resistant treatment POPP, who had significant resolution of symptoms and inflammatory lesions on post-treatment MRI with secukinumab 150 mg. We also identified 31 cases of POPP (27 males; mean age 44.9 years) in the literature review. There was great toe involvement in 24 cases, and distal interphalangeal (DIP) involvement in 14 cases, with frequent radiographically evident damage. Seventeen of 31 patients received systematic treatment other than biologics, mostly MTX, with no satisfactory results. Anti-TNF agents were used successfully in 5 cases, mostly after disease modifying anti-rheumatic drug (DMARD) failure. Imaging studies in nail psoriasis and DIP psoriatic arthritis have shown an anatomical link among the nail, the DP bone, and the DIP joint entheses, suggesting that POPP may be a subtype of nail disease with excessive involvement of DP tissues (nail, soft tissue, enthesis, and bone). IL-17 inhibition could be an alternative therapeutic option in DMARD-resistant cases of POPP. Conventional treatment achieves modest success, but anti-TNF agents appear to be much more effective. Based on imaging studies, POPP may be a particular subtype of nail disease.


Subject(s)
Arthritis, Psoriatic , Nail Diseases , Periostitis , Adult , Arthritis, Psoriatic/complications , Arthritis, Psoriatic/diagnostic imaging , Arthritis, Psoriatic/drug therapy , Humans , Interleukin-17 , Male , Middle Aged , Nail Diseases/drug therapy , Periostitis/diagnostic imaging , Periostitis/drug therapy , Tumor Necrosis Factor Inhibitors
7.
Quintessence Int ; 49(3): 219-226, 2018.
Article in English | MEDLINE | ID: mdl-29399678

ABSTRACT

Chronic non-suppurative osteomyelitis (CNSO) is a chronic bone disease and may be associated with a reparative periosteum entity called proliferative periostitis (PP). This condition rarely affects the maxillofacial region. Mandibular cases were already described for an infectious dental cause, often with an "onion skin" radiographic aspect, but some rare reported cases showed no obvious etiology. They represent a challenge for diagnosis because of possible misdiagnosis leading to unsuccessful or inappropriate treatment attempts. An uncommon case of mandibular CNSO associated with PP in a 9-year-old boy with no obvious infectious or inflammatory causes is reported. Clinical and radiographic examinations revealed a swelling in the left hemimandible, associated with multiple osteolytic areas inside both medullary and newly formed periosteal bone and cortical bone perforations. Recovery signs were seen after a 22-month follow-up period, and radiographic signs of bone healing were observed. From this new case report, a review of the literature was performed on reported cases of mandibular CNSO with PP, and discussed the etiological, clinical, radiologic, and therapeutic aspects of this pathology. This work highlights the importance of considering CNSO with PP in the differential diagnosis of one-sided painless mandibular swellings, even in the absence of an obvious cause.


Subject(s)
Mandibular Diseases/diagnosis , Osteomyelitis/diagnosis , Periostitis/diagnosis , Anti-Bacterial Agents/therapeutic use , Child , Chronic Disease , Diagnosis, Differential , Diagnostic Imaging , Humans , Male , Mandibular Diseases/drug therapy , Osteomyelitis/drug therapy , Periostitis/drug therapy
8.
Toxicon ; 141: 15-17, 2018 Jan.
Article in English | MEDLINE | ID: mdl-29146176

ABSTRACT

Local anesthesia is an effective method to control pain. Neosaxitoxin is a phycotoxin whose molecular mechanism includes a reversible inhibition of voltage-gated sodium channels at the axonal level, impeding nerve impulse propagation. The present study was designed to evaluate the clinical efficacy of Neosaxitoxin as a local long-acting pain blocker in horse bucked shins, and it was found to effectively control pain. While Neosaxitoxin and Gonyautoxin, another Paralytic Shellfish Poison (PSP) toxin, have been successfully used in humans as long-lasting pain blockers, this finding marks the first time a PSP has been shown to have an established effect in veterinary medicine.


Subject(s)
Anesthetics, Local/therapeutic use , Horse Diseases/drug therapy , Pain/veterinary , Periostitis/veterinary , Saxitoxin/analogs & derivatives , Anesthetics, Local/administration & dosage , Animals , Horses , Infusions, Subcutaneous/veterinary , Lameness, Animal/drug therapy , Pain/drug therapy , Periostitis/drug therapy , Saxitoxin/administration & dosage , Saxitoxin/therapeutic use
9.
Clin Exp Rheumatol ; 35(3): 516-517, 2017.
Article in English | MEDLINE | ID: mdl-28339360

ABSTRACT

OBJECTIVES: In 1966, Goldbloom et al. described two children who developed a peculiar clinical picture characterized by intermittent daily bone pain in the lower limbs, fever spikes, increased acute phase reactants and dysproteinaemia. The syndrome occurred two weeks after a group A ß-haemolytic streptococcus infection. So far, only a few cases have been reported in the medical literature in English. METHODS: We report two further cases of Goldbloom's syndrome with a review of the literature in English. RESULTS: Our two patients lived in the same Italian region and presented their syndrome onset a week apart. Early use of STIR MRI revealed an atypical metaphyseal hyperintensity in the femurs and tibias. X-ray showed periosteal hyperostosis. A short cycle of corticosteroids led to rapid recovery of symptoms and disappearance of bone changes. CONCLUSIONS: The reported cases highlight a likely under-recognised post-streptococcal inflammatory periosteal reaction and emphasise the diagnostic utility of the newer imaging modalities.


Subject(s)
Femur/diagnostic imaging , Hypergammaglobulinemia/blood , Hypoalbuminemia/blood , Magnetic Resonance Imaging , Periostitis/diagnostic imaging , Streptococcal Infections/complications , Tibia/diagnostic imaging , Adrenal Cortex Hormones/therapeutic use , Biomarkers/blood , Child , Early Diagnosis , Female , Femur/microbiology , Humans , Hypergammaglobulinemia/diagnosis , Hypergammaglobulinemia/drug therapy , Hypergammaglobulinemia/microbiology , Hypoalbuminemia/diagnosis , Hypoalbuminemia/drug therapy , Hypoalbuminemia/microbiology , Periostitis/drug therapy , Periostitis/microbiology , Predictive Value of Tests , Prednisone/therapeutic use , Streptococcal Infections/diagnosis , Streptococcal Infections/microbiology , Syndrome , Tibia/microbiology , Treatment Outcome
10.
Am J Trop Med Hyg ; 96(5): 1039-1041, 2017 May.
Article in English | MEDLINE | ID: mdl-28193743

ABSTRACT

AbstractThe etiologic agent of yaws, Treponema pallidum subsp. pertenue, causes a multistage infection transmitted by nonsexual contact with the exudates from active lesions. Bone lesions in the form of osteoperiostitis are common and occur in numerous bones simultaneously in early stages. Although a multinational eradication campaign with mass administration of intramuscular benzathine benzylpenicillin in the 1950s greatly reduced its global incidence, a resurgence of yaws has occurred since around 2000 in western and central Africa and the Pacific Islands. The finding that a single oral dose of azithromycin (30 mg/kg) was as effective as benzathine benzylpenicillin prompted renewed interest by World Health Organization in 2012 toward eradication of this infection by 2020. We previously reported the excellent response to benzathine benzylpenicillin therapy for yaws osteoperiostitis. Herein, we document a confirmed case of yaws with osteoperiostitis successfully treated with single-dose azithromycin and discuss the pathology of yaws periostitis and comment on the implications of this in light of the new campaign toward yaws eradication.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Azithromycin/therapeutic use , DNA, Bacterial/isolation & purification , Periostitis/drug therapy , Treponema pallidum/drug effects , Yaws/drug therapy , Child, Preschool , Humans , Leg/diagnostic imaging , Leg/microbiology , Leg/pathology , Male , Periosteum/diagnostic imaging , Periosteum/drug effects , Periosteum/microbiology , Periosteum/pathology , Periostitis/diagnostic imaging , Periostitis/microbiology , Periostitis/pathology , Tomography, X-Ray Computed , Treatment Outcome , Treponema pallidum/genetics , Treponema pallidum/isolation & purification , Wrist/diagnostic imaging , Wrist/microbiology , Wrist/pathology , Yaws/diagnostic imaging , Yaws/microbiology , Yaws/pathology
11.
Pediatr Ann ; 45(5): e176-9, 2016 May 01.
Article in English | MEDLINE | ID: mdl-27171806

ABSTRACT

Acute mastoiditis (AM) is a relatively rare complication of acute otitis media (AOM). The most common pathogens include Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus. Pneumococcal vaccination and changes in antibiotic prescribing recommendations for AOM may change the incidence of AM in the future. Diagnosis of AM can be made based on clinical presentation, but computed tomography of the temporal bone with contrast should be considered if there is concern for complicated AM. Both extracranial and intracranial complications of AM may occur. Previously, routine cortical mastoidectomy was recommended for AM treatment, but new data suggest that a more conservative treatment approach can be considered, including intravenous (IV) antibiotics alone or IV antibiotics with myringotomy. [Pediatr Ann. 2016;45(5):e176-e179.].


Subject(s)
Mastoiditis/microbiology , Otitis Media with Effusion/microbiology , Pneumococcal Infections/microbiology , Streptococcus pneumoniae/isolation & purification , Abscess/diagnostic imaging , Abscess/drug therapy , Abscess/microbiology , Acute Disease , Anti-Bacterial Agents/therapeutic use , Ceftriaxone/therapeutic use , Female , Humans , Infant , Mastoid/pathology , Mastoid/surgery , Mastoiditis/diagnosis , Mastoiditis/therapy , Otitis Media with Effusion/drug therapy , Periosteum/diagnostic imaging , Periostitis/diagnostic imaging , Periostitis/drug therapy , Periostitis/microbiology , Pneumococcal Infections/drug therapy , Tomography, X-Ray Computed
13.
J Dermatol ; 42(10): 996-8, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26010891

ABSTRACT

Ustekinumab is a human monoclonal antibody that specifically binds to the p40 subunit of interleukin (IL)-12 and IL-23, inhibiting the activity of both cytokines, thereby blocking the T-helper (Th)1 and Th17 inflammatory pathways. While biologic agents have dramatically changed the strategies of psoriasis treatment, increasing cases of autoimmune diseases during the use of such agents have been reported. We experienced a case of bullous pemphigoid occurring during treatment of a rare variant of psoriatic arthritis, psoriatic onycho-pachydermo periostitis with ustekinumab. Only six cases of autoimmune blistering diseases during treatment with biologic agents have ever been reported including our case, and we herein review the published work of these cases. Dermatologists must be attentive to the possibility of autoimmune blistering diseases during ustekinumab treatment.


Subject(s)
Arthritis, Psoriatic/drug therapy , Dermatologic Agents/adverse effects , Pemphigoid, Bullous/chemically induced , Periostitis/drug therapy , Ustekinumab/adverse effects , Humans , Male , Middle Aged
14.
Transpl Infect Dis ; 15(4): 424-9, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23663268

ABSTRACT

Fungal infections are common in solid organ transplantation. An increasing number of transplant recipients receive antifungal therapy for prolonged duration owing to invasive fungal infections. Herein, we describe a diagnosis of periostitis as a complication of chronic use of voriconazole in a lung transplant recipient. The patient was diagnosed with probable pulmonary aspergillosis and was treated with oral voriconazole for a total of 9 months. Evidence of multifocal periostitis was observed in the axial and appendicular skeleton. Early recognition of this phenomenon is important to prevent unnecessary tests and procedures. Prompt discontinuation of voriconazole should result in improvement of symptoms.


Subject(s)
Antifungal Agents/adverse effects , Lung Diseases, Fungal/drug therapy , Lung Transplantation/adverse effects , Periostitis/microbiology , Pulmonary Aspergillosis/drug therapy , Pyrimidines/adverse effects , Triazoles/adverse effects , Aged , Antifungal Agents/therapeutic use , Chemoprevention , Female , Humans , Lung Diseases, Fungal/complications , Lung Diseases, Fungal/microbiology , Male , Periostitis/complications , Periostitis/diagnosis , Periostitis/drug therapy , Pulmonary Aspergillosis/complications , Pulmonary Aspergillosis/microbiology , Pyrimidines/therapeutic use , Triazoles/therapeutic use , Voriconazole
15.
Pediatr Dermatol ; 30(6): 758-60, 2013.
Article in English | MEDLINE | ID: mdl-22471702

ABSTRACT

We describe a 3-month-old infant who presented to our institution with interleukin (IL)-1 receptor antagonist deficiency (DIRA), which consists of neutrophilic pustular dermatosis, periostitis, aseptic multifocal osteomyelitis, and persistently high acute-phase reactants. Skin findings promptly improved upon initiation of treatment with anakinra (recombinant human IL-1 receptor antagonist), and the bony lesions and systemic inflammation resolved with continued therapy.


Subject(s)
Hereditary Autoinflammatory Diseases/drug therapy , Interleukin 1 Receptor Antagonist Protein/therapeutic use , Osteomyelitis/drug therapy , Periostitis/drug therapy , Skin Diseases, Vesiculobullous/drug therapy , Antirheumatic Agents/therapeutic use , Female , Hereditary Autoinflammatory Diseases/complications , Humans , Infant , Osteomyelitis/etiology , Periostitis/etiology , Skin Diseases, Vesiculobullous/etiology
16.
Stomatologiia (Mosk) ; 91(6): 63-6, 2012.
Article in Russian | MEDLINE | ID: mdl-23268223

ABSTRACT

The paper presents the results of clinical examination of 114 patients aged 60-88 years with acute odontogenous periostitis receiving treatment in in-patient maxillofacial surgery unit. The dynamic of clinical symptoms is used to carry out the comparative effectiveness study of several peroral antibiotics in elderly patients.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Jaw Diseases/drug therapy , Jaw Diseases/microbiology , Periostitis/drug therapy , Periostitis/microbiology , Acute Disease , Aged , Aged, 80 and over , Amoxicillin-Potassium Clavulanate Combination/therapeutic use , Ciprofloxacin/analogs & derivatives , Female , Fluoroquinolones/therapeutic use , Humans , Jaw Diseases/diagnosis , Male , Middle Aged , Ofloxacin/therapeutic use , Periostitis/diagnosis , Suppuration/diagnosis , Suppuration/drug therapy , Suppuration/microbiology , Treatment Outcome
18.
Lepr Rev ; 83(1): 98-103, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22655475

ABSTRACT

Florid reactive periostitis ossificans is a rare bone lesion usually occurring in the small, tubular bones of the hands and feet. This entity is a benign and aggressive periosteal reaction associated with soft tissue swelling that appears similar to a bone lesion that radiographically and clinically mimics an infectious or neoplastic process. Typically the lesions occurs in an adolescent or young adult and presents as a small area of painful swelling and erythema over the affected bone. The cause of florid reactive periostitis ossificans is not exactly known though many authors have postulated varied etiopathogenesis for the same condition. In this report, is a very rare and unusual example of this entity that has been observed in association with erythema nodosum leprosum (ENL) a type 2 lepra reaction in a Leprosy patient.


Subject(s)
Erythema Nodosum/complications , Leprosy, Lepromatous/drug therapy , Periostitis/complications , Adolescent , Clofazimine/administration & dosage , Dapsone/administration & dosage , Erythema Nodosum/drug therapy , Humans , Leprostatic Agents/administration & dosage , Leprosy, Lepromatous/pathology , Male , Osteitis/drug therapy , Osteitis/pathology , Periostitis/diagnostic imaging , Periostitis/drug therapy , Periostitis/pathology , Radiography , Rifampin/administration & dosage , Treatment Outcome
19.
Rheumatol Int ; 32(5): 1449-52, 2012 May.
Article in English | MEDLINE | ID: mdl-21448639

ABSTRACT

Psoriatic onycho-pachydermo-osteo/periostitis (POPP) syndrome is a rare form of psoriatic arthritis with a combination of (i) psoriatic onychodystrophy, (ii) connective tissue thickening, and (iii) periostitis of the distal phalanges. The treatment of the condition has generally been reported to be unsatisfactory with the traditional regimes. Here, we describe a case whom we believe is one presentation of POPP with extensive bone marrow edema of metacarpal bones without distinctive periostitis.


Subject(s)
Arthritis, Psoriatic/diagnosis , Bone Marrow Diseases/diagnosis , Connective Tissue Diseases/diagnosis , Edema/diagnosis , Metacarpal Bones/pathology , Nail Diseases/diagnosis , Periostitis/diagnosis , Arthritis, Psoriatic/drug therapy , Arthritis, Psoriatic/pathology , Bone Marrow Diseases/drug therapy , Bone Marrow Diseases/pathology , Connective Tissue Diseases/drug therapy , Connective Tissue Diseases/pathology , Drug Therapy, Combination , Edema/drug therapy , Edema/pathology , Humans , Immunosuppressive Agents/therapeutic use , Magnetic Resonance Imaging , Male , Metacarpal Bones/diagnostic imaging , Metacarpal Bones/drug effects , Nail Diseases/drug therapy , Nail Diseases/pathology , Periostitis/drug therapy , Periostitis/pathology , Syndrome , Tomography, X-Ray Computed , Treatment Outcome , Young Adult
20.
Clin Infect Dis ; 52(6): 771-4, 2011 Mar 15.
Article in English | MEDLINE | ID: mdl-21367729

ABSTRACT

We describe the clinical and radiological manifestations and outcome after treatment of 7 children who received a diagnosis of early yaws osteoperiostitis. Osteoperiostitis occurred some weeks after the primary infection, and the most common finding was hypertrophic periostitis of long bones. All treated patients had excellent responses to benzyl-penicillin therapy.


Subject(s)
Periostitis/diagnosis , Periostitis/pathology , Yaws/complications , Yaws/pathology , Anti-Bacterial Agents/administration & dosage , Bone and Bones/pathology , Child , Child, Preschool , Female , Humans , Male , Penicillin G/administration & dosage , Periostitis/diagnostic imaging , Periostitis/drug therapy , Radiography , Time Factors , Treatment Outcome , Treponema pallidum/isolation & purification , Yaws/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...